Antimicrobial susceptibility testing

MICRONAUT IVD System

A broad range of antibiotic resistance and speciality antimicrobial susceptibility testing

Highlights

MICRONAUT IVD system offers a range of antibiotic resistance and specialty susceptibility testing

The MICRONAUT IVD System encompasses a range of plates for detection of resistance mechanisms and specific resistances of clinical and/or epidemiological importance, including antimicrobial susceptibility testing (AST) with standard minimum inhibitory concentration (MIC) plates, covering an extended spectrum of organisms in microbiology.

Eigenschaften

Routine microbiology laboratories are in need of an efficient tool for phenotypic detection of important antimicrobial resistance mechanisms, such as resistance genes encoding for certain ß-lactamases (e.g. ESBL or carbapenemases). These mechanisms are quickly and efficiently transferred between pathogens, causing concern over the effectiveness of key antibiotics.

Broad resistance coverage

The MICRONAUT system provides antimicrobial susceptibility testing (AST/AFST) either with standard MIC plates with a dedicated layout or with individual customized layouts.

In addition, the MICRONAUT system offers the detection of clinically relevant resistant mechanisms in gram-negative and gram-positive bacteria.

The flexibility of the MICRONAUT system allows laboratories to adjust their testing profiles to the rapid spread of newly emerging resistances.

MICRONAUT AST

The test principle of the MICRONAUT system for AST is based on phenotypic detection of resistance as expressed by microbial growth in the presence of antibiotic compounds. The broth microdilution (BMD) procedure is a standardized method and a worldwide accepted reference system for determination of true MIC values.

Users can choose preferred standards, such as EUCAST or CLSI, and compose customized antibiograms from more than 200 antibiotics, or select from a range of standard layouts. MICRONAUT-S and MICRONAUT-AM plates, as well as MIC-Strip manual susceptibility testing, are designed for in vitro diagnostic use.

 

Please contact your local representative for availability in your country.

Not for sale in the USA. MERLIN Gesellschaft für mikrobiologische Diagnostika mbH – A Bruker Company (www.merlin-diagnostika.de)

Mehr Informationen

Related products

merlin-micronaut-s-title

MICRONAUT-S MRSA GP

Based on the broth microdilution (BMD) procedure, the MICRONAUT-S MRSA/GP system provides the phenotypic detection of clinically relevant single or multi-resistance in staphylococci, enterococci and streptococci organisms. The susceptibility testing with highly effective back up antibiotics like ceftaroline, linezolid, tigecycline, daptomycin, and vancomycin offers therapeutic options in case of multi-drug resistance.
micronaut-s-ß-lactamases-carbapenemases-bruker-merlin-md-web

MICRONAUT-S ß-Lactamases & MICRONAUT-S Carbapenemases Detection

Based on the standard broth microdilution (BMD) method, the MICRONAUT-S ß-Lactamases and MICRONAUT-S Carbapenemases Detection systems are the only broth microdilution based systems that can differentiate between all Ambler class A (ESBL, KPC), class B (MBL), class C (AMP-C) and class D (OXA-48-like) cephalosporinases and / or carbapenemases.
merlin-micronaut-s-title

MICRONAUT-S MDR MRGN-Screening

Based on the standard broth microdilution (BMD) procedure, the antimicrobial susceptibility testing (AST) plate MICRONAUT-S MDR MRGN Screening provides the phenotypic detection of clinically relevant resistance mechanisms, including confirmation of cephalosporinases and carbapenemases in Enterobacterales and non-fermenters.
merlin-micronaut-s anaerobes-title

MICRONAUT-S Anaerobes MIC

Based on the broth microdilution (BMD) procedure, the AST plate MICRONAUT-S Anaerobes MIC provides the tool for phenotypic detection of clinically relevant resistance mechanisms in anaerobic pathogens such as Clostridium spp., Bacteroides spp. and Peptostreptococcus spp.
micronaut-am-bruker-merlin-md-web

MICRONAUT-AM

The increasing prevalence and severity of fungal infections in healthcare scenarios requires a standardized routine antifungal susceptibility test (AFST) in the microbiology lab. The MICRONAUT-AM system uses MIC plates for the automated or manual susceptibility testing of yeast and cryptococci.
merlin-micronaut-s pneumococci and haemophilus mic-penicillin-title

MICRONAUT-S Pneumococci & Haemophilus MIC

Based on the standard broth microdilution (BMD) method, the routine antimicrobial susceptibility testing (AST) plate MICRONAUT-S Pneumococcus & Haemophilus MIC provides the phenotypic quantification of MIC values for 14 different antibiotics and antibiotic combinations commonly used for treatment of infections caused by Streptococcus pneumoniae and Haemophilus influenzae.
micronaut-s-pseudomonas-mic-bruker-merlin-md-web

MICRONAUT-S Pseudomonas MIC

Based on the standard broth microdilution (BMD) method, the antimicrobial susceptibility testing (AST) plate MICRONAUT-S Pseudomonas MIC provides the phenotypic quantification of MIC values for critically important antibiotics and back up antibiotics used for treatment of infections caused by non-fermenting pathogens like Pseudomonas aeruginosa, Acinetobacter baumannii, and Stenotrophomonas maltophilia.
mic-strips-bruker-merlin-md-web

BMD MIC-Strips

BMD MIC-Strips are quantitative assays using the broth microdilution method, for determining the minimum inhibitory concentration (MIC) of antimicrobial agents (colistin, piperacillin-tazobactam, vancomycin/teicoplanin) against microorganisms to indicate appropriate patient treatment and for identifying resistance patterns.